主权项 |
1. A compound of the following formula: or a pharmaceutically acceptable salt thereof, wherein:
(a) R2 is CH3, CH2F, CHF2, CF3, F, CN, C2-4 alkenyl, C2-4 alkynyl, or C1-4 alkyl optionally substituted with amino, hydroxy, or 1 to 3 fluorine atoms;(b) R is H, phosphate, H-phosphonate, acyl, alkyl, 0-substituted carboxyalkylamino, sulfonate ester, or benzyl, wherein the phenyl group of the benzyl is optionally substituted, a lipid, an L or D-amino acid, a carbohydrate, a peptide, or a cholesterol;(c) R3 is OH, H, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, vinyl, N3, CN, Cl, Br, F, I, NO2, C(O)O(C1-4 alkyl), C(O)O(C1-4 alkyl), C(O)O(C2-4 alkynyl), C(O)O(C2-4 alkenyl), O(C1-10 acyl), O(C1-4 alkyl), O(C2-4 alkenyl), SH, S(C1-4 acyl), S(C1-4 alkyl), S(C2-4 alkynyl), S(C1-4 alkenyl), SO(C1-4 acyl), SO(C1-4 alkyl), SO(C2-4 alkynyl), SO(C2-4 alkenyl), SO2(C1-4 acyl), SO2(C1-4 alkyl), SO2(C2-4 alkynyl), SO2(C2-4 alkenyl), OS(O)2(C1-4 acyl), OS(O)2(C1-4 alkyl), OS(O)2(C2-4 alkenyl), NH2, NH(C1-4 alkyl), NH(C2-4 alkenyl), NH(C2-4 alkynyl), NH(C1-4 acyl), N(C1-4 alkyl)2, or N(C1-18 acyl)2,wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N3, CN, one to three halogens, NO2, C(O)O(C1-4 alkyl), C(O)O(C1-4 alkyl), C(O)O(C2-4 alkynyl), C(O)O(C2-4 alkenyl), O(C1-4 acyl), O(C1-4 alkyl), O(C2-4 alkenyl), SH, S(C1-4 acyl), S(C1-4 alkyl), S(C2-4 alkynyl), S(C2-4 alkenyl), SO(C1-4 acyl), SO(C1-4 alkyl), SO(C2-4 alkynyl), SO(C2-4 alkenyl), SO2(C1-4 acyl), SO2(C1-4 alkyl), SO2(C2-4 alkynyl), SO2(C2-4 alkenyl), OS(O)2(C1-4 acyl), OS(O)2(C1-4 alkyl), OS(O)2(C2-4 alkenyl), NH2, NH(C1-4 alkyl), NH(C2-4 alkenyl), NH(C2-4 alkynyl), NH(C1-4 acyl), N(C1-4 alkyl)2, or N(C1-4 acyl)2;(d) R4 is a lower alkyl, CN, vinyl, O-(lower alkyl), hydroxyl lower alkyl, CH2F, N3, CH2CN, CH2NH2, CH2NHCH3, CH2N(CH3)2, an optionally substituted ethynyl, halogen, alkenyl, alkynyl, Br-vinyl, hydroxy, O-alkenyl, NO2, amino, lower alkylamino, or di(C1-8 alkyl)amino;(e) R and R3 can together form 5′,3′-cyclic phosphate;(f) Base is a naturally occurring or modified pyrimidine base represented by the following structure: wherein;R5 and R6, are independently H, F, Cl, Br, I, OH, OR′, SH, SR′, NH2, NHR′, NR′2, alkyl of C1-C6, halogenated alkyl of C1-C6, lower alkenyl of C2-C6, halogenated lower alkenyl of C2-C6, lower alkynyl of C2-C6, halogenated lower alkynyl of C2-C6, lower alkoxy of C1-C6, halogenated lower alkoxy of C1-C6, CO2H, CO2R′, CONH2, CONHR′, CONR′2, CH═CHCO2H, or CH═CHCO2R′,wherein R′ is an optionally substituted alkyl; an optionally substituted cycloalkyl; an optionally substituted alkynyl of C2-C6, an optionally substituted lower alkenyl of C2-C6, or optionally substituted acyl, optionally substituted aryl, optionally substituted C1-C4 alkylaryloxy, heteroaryl, optionally substituted C1-C4 alkylheteroaryl, an optionally substituted alkoxy C1-20 alkyl, an optionally substituted amino C1-20 alkyl, or an optionally substituted fluoro C1-20 alkyl. |